View Article

Abstract

Parenteral preparations, which include injections, infusions, and sterile implants, are critical dosage forms used for the rapid and direct delivery of therapeutic agents into the systemic circulation. Their manufacturing requires stringent control to ensure sterility, safety, and efficacy. This comprehensive review highlights the formulation, production processes, and quality control of parenteral products in compliance with global regulatory guidelines. It discusses various routes of administration, types of parenteral preparations based on composition and volume, and key formulation components such as vehicles, preservatives, stabilizers, and solubilizing agents. The review also emphasizes the importance of aseptic processing, sterilization methods, and container-closure integrity in maintaining product quality. Furthermore, it compares major international regulatory frameworks, including those from the World Health Organization (WHO), U.S. Food and Drug Administration (FDA), and European Medicines Agency (EMA), which ensure adherence to Good Manufacturing Practices (GMP) and product safety standards. Overall, the study underscores the critical role of harmonized global regulations in the consistent production of safe and effective parenteral pharmaceuticals.

Keywords

Parenteral preparations, Sterility, GMP, FDA, WHO, EMA, Regulatory guidelines, Pharmaceutical manufacturing

Introduction

Parenteral preparations consist of injection gels, implants, solutions, suspensions, emulsions for injection or infusion, and powders for injection or infusion. These are aseptic formulations designed to be administered directly into an animal's or human's systemic circulation by injection. They must meet pharmacopeia-described pharmaceutical quality requirements and are safe for the intended usage, much like other pharmaceutical dosage forms. Both pyrogen-free and sterile parenteral preparations are required. While the pyrogen-free requirement calls for the use of pyrogen-free pharmaceutical ingredients, drug substances, or APIs (Active Pharmaceutical Ingredients), and excipients during the preparation of the sterile drug products in the absence of a dehydrogenation process, sterility can be achieved through a variety of sterilisation procedures that should be suitable for the formulations. Parenteral preparations are a vital component of modern healthcare because they let medications, nutrients, and fluids be directly administered into the bloodstream. his mode of delivery becomes essential when taking medications orally or when prompt therapeutic effects are required. We explore the wide realm of parenteral preparations in this, looking at its many forms, numerous advantages, unique challenges, and vital safety concerns. Parenteral preparations are an integral aspect of modern medicine since they are vital to the direct administration of medications, nutrients, and fluids into the bloodstream. This mode of delivery becomes essential when taking medications orally or when prompt therapeutic effects are required. Parenteral preparations are administered using a range of formulations, including suspensions, emulsions, solutions, and lyophilised powders for reconstitution. Drug molecules are dissolved in the proper solvent to provide rapid and efficient delivery in the most commonly utilised form, solutions. Conversely, emulsions employ immiscible liquid phases to facilitate the administration of lipid-based drugs, some of which might not dissolve completely in aqueous solutions. Suctions, which include solid particles suspended in a liquid medium, can be used to administer medications that are not able to be produced as solutions. Furthermore, because lyophilised powders are stable and portable, they are ideal for a number of drugs and therapies, however reconstitution is necessary prior to usage. Parenteral preparations have numerous advantages over alternative medication administration techniques. Parenteral preparations are medicinal products administered by methods other than oral ones. Insults and transfusion fluids. A sterile solution in an aqueous or greasy medium is injected into the body through one or more layers of the skin and mucous.

Advantages of Parenteral Preparation:

  • Parenteral preparation onset of action is rapid
  • Parenteral preparation are useful in
  • Unconscious patients or unreliable patients
  • Patients suffer from vomiting and diarhoe
  • Certain parenteral preparation provides prolong drug action e.g. penicillin G provide action up to a month when administered intramuscular route. [3] Parenteral route is sutaible for irritant drug and high first pass
  • Transfusion fluid containing nutritives like glucose and electrolytes such as sodium chloride can be given by this route. 
  • The drug cannot administer by oral route parenteral route is useful.
  • Parenteral preparation is use in emergency cases because onset of action is fast. (such as epilepsy, asthma).

Disadvantages of Parenteral Preparation

  • Injection causes pain at the site of administration of drug. Or local irritation as a result of needle insertion ? High cost of production.
  • They cannot easily self-administration. Trained persons are required to administered the drug.
  • Administration of drug through wrong route of injection may prove to be fatal
  • In case drug is overdose it is difficult to save a patient
  • There are chances of allergic reaction of a drug by individual. This reaction are very fatal and lead to death
  • They required aseptic condition or follow proper aseptic technique during manufacturing
  • It poses more risks than the other route
  • Parenteral preparation are required aseptic technique during production.

Types of parental products--

[1] Base on Route of Administration.  

1) Intradermal Injection -

These are given in between dermis and epidermis. Skin of the left forearm is usually selected forgiven injection. Generally, 0.1 to 0.2ml of parenteral solution is injected by this route. The route is used for diagnostic purposes and for testing the sensitivity of the injectable For certain substances, administration via an ID route can result in a faster systemic uptake compared with subcutaneous injections, leading to a stronger immune response to vaccinations, immunology and novel cancer treatments, and faster drug uptake. Additionally, since administration is closer to the surface of the skin, the body's reaction to substances is more easily visible. 

Reference

  1. Remington, the Science and Practice of Pharmacy, Parenteral Preparation, 20th edition. Philadelphia: ISE Publication. 2000; 1.
  2. Ford JL. Parenteral products. In: Aulton ME, (ed.) Pharmaceutics: The Science of Dosage Form Design. New York; Longman. 1988.
  3. “Parenteral dosage forms (page no. 331-353).
  4. Ansel HC., et al. Pharmaceutical dosage forms and drug delivery system, 7th edition. Lippincott Williams and Wilkins: Philadelphia. 1999.
  5. Kumar Radha Santosh, and Tulja Kumari Parenteral suspension: stability enhancing liquid dosage form journal of drug delivery and therapeutic 9.4-A (2019):803-805.
  6. Pande, Anjali Amrit Lal. Development and manufacturing of injectable (Parenteral drug product (2019)
  7. Thomas, Sneha, S. Mahendran, and R. Selvakumar. “Formulation and Evaluation of an Injectable Solution as a Dosage Form” Journal of Drug Delivery and Therapeutics 8.5(2018) :81-87.
  8. Anu Kaushik, Vivek Chauhan, “Recent Review On Parenteral Products- Sterile Dosage
  9. Form,” (Page no.970-975) vol-3 (2017). 
  10. Kwatara, Shubhika, Guncha Taneja, and Nimisha Nasa. “Alternative routes of administration- transdermal, pulmonary and parenteral.” Indo Global Journal of Pharmaceutical Science 2.4(2012).:409-426.
  11. Alton Michael E. “Pharmaceutics the Design and Manufacture of Medicines” Kelvin M.G
  12. Tylor, Robert Low, Parenteral drug delivery ,4th edition (Page no 623-636)
  13. Dongare, Sujata D. Sachin S. Mali, and Prasad V. Patrekar. “Sterile Parenteral Products: a narrative approach. Journal of drug delivery and therapeutics 5.1 (2015): 41-48.
  14. Balakrishna, T., et al. “Pharmaceutical Sciences.”
  15. Nasa, Praveen. “A review on pharmaceutical Packaging Material. World Journal of Pharmaceutical Research, 3(), 344-368. 
  16. Chapman, Derek G. “Parenteral product. “Pharmacy Practice E-Book (2019):195.
  17. Dr. Manish Mishra “Pharmaceutical Dosage Form and Cosmetic Technology” Parenteral (Page no 205-219).
  18. Lachman and Leon, Herbert A. Lieberman, Joseph L. Kanig, “Sterile Product” (Page no 639). 
  19. Ali, Heyam Saad. “A Comprehensive Review in Parenteral Formulation. Volume 3(2020): 43-49. 
  20. Prevesh Kumar, Pawan Singh and Mr. Mohd. Semimum Akthar “International Journal of Advance Research “Review Article
  21. Puneet Dwivedi, Ajay Kumar, Egyptian Journal of Anaesthesia, 2017
  22. S. Siracusano, S. Ciciliato, G. Ollandini and F. Visalli Department of Urology – Trieste University Italy Clinical Management of Complicated Urinary Tract Infection, Catheters and Infections. 2011; 83 -97.
  23. Types of Stents and Their Uses (webmd.com)
  24. Patil DJ., Hospital, and clinical Pharmacy, Nirali Prakashan, 2nd ed, 2008; 9: 4-9.8.
  25. Puneet Dwivedi, Ajay Kumar, Egyptian Journal of Anaesthesia, 2017, Urinary Catheters: Uses, Types, and Complications (healthline.com), Tube feeding - St. Jude Children’s Research Hospital.
  26. The United States Pharmacopeia, the National Formulary. US Pharmacopeia Convention, Rockville, MD, 1995; 1775-7. Encyclopedia of Controlled Release. John Wiley and Sons, Inc: New York. 1952; 1-2: 743-77.
  27. Singh M and Ravin L. Parenteral emulsions as drug carrier systems. Journal of Parenteral Science and Technology. 1986; 40: 34-44.
  28. Date AA., et al. Parenteral microemulsions: An overview. International Journal of Pharmaceutics. 2008; 355: 19-30.
  29. JK Haleblian. Characterization of Habits and Crystalline Modifications of Solids and Their Pharmaceutical Applications. Journal of Pharmaceutical Sciences. 1975; 64(8): 12691288.

Photo
Hrishikesh Bhakade
Corresponding author

SND College of Pharmacy

Photo
Vikas Shinde
Co-author

SND College of Pharmacy

Photo
Trupti Bankar
Co-author

SND College of Pharmacy

Photo
Parth Khandelwal
Co-author

SND College of Pharmacy

Hrishikesh Bhakade*, Vikas Shinde, Trupti Bankar, Parth Khandelwal, A Comprehensive Review of Global Regulatory Guidelines for Parenteral Manufacturing, Int. J. Sci. R. Tech., 2025, 2 (11), 32-45. https://doi.org/10.5281/zenodo.17516557